scPharmaceuticals Inc.
SCPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $157,600 | $241,481 | $203,330 | $137,306 |
| - Cash | $75,655 | $46,814 | $71,061 | $74,268 |
| + Debt | $52,693 | $40,269 | $37,368 | $17,635 |
| Enterprise Value | $134,638 | $234,936 | $169,637 | $80,673 |
| Revenue | $36,332 | $13,593 | $0 | $0 |
| % Growth | 167.3% | – | – | – |
| Gross Profit | $24,971 | $9,782 | -$468 | -$438 |
| % Margin | 68.7% | 72% | – | – |
| EBITDA | -$77,430 | -$46,061 | -$33,068 | -$25,021 |
| % Margin | -213.1% | -338.9% | – | – |
| Net Income | -$85,148 | -$54,810 | -$36,838 | -$28,034 |
| % Margin | -234.4% | -403.2% | – | – |
| EPS Diluted | -1.91 | -1.42 | -1.3 | -1.02 |
| % Growth | -34.5% | -9.2% | -27.5% | – |
| Operating Cash Flow | -$70,538 | -$59,244 | -$34,577 | -$27,151 |
| Capital Expenditures | -$21 | -$40 | -$21 | -$9 |
| Free Cash Flow | -$70,559 | -$59,284 | -$34,598 | -$27,160 |